Brussels has decided not to renew the contract with the British-Swedish company for the supply of vaccines in the second half of this year, Reuters reports, citing Thierry Breton.
The European Commissioner for Internal Market Affairs does not plan to renew the contract for the supply of Vaxzevria to the European Union. Earlier in April, the European Commission initiated legal proceedings for failure to fulfill an existing contract against AstraZeneca. According to a preliminary order, in the first quarter of this year the company was supposed to deliver 120 million doses, but in reality the EU received only about 40 million.
After cases of thrombosis due to the AstraZeneca vaccine, EU member states did not accept a uniform line, and some have suspended the use of this drug in people over a certain age. Regarding examples of countries where vaccination is restricted, it is worth noting that in Germany, Spain, Italy, the Netherlands and Estonia, the AstraZeneca vaccine has been “frozen” for persons under 60 years of age. In France and Belgium, the vaccine is only given to people over 55, while in Finland it is recommended only to people over 65. AstraZeneca vaccination has also been suspended in Denmark.
More than 158 million people on the planet have been infected to date with COVID-19, about 3.3 million have died.